A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection

被引:25
作者
DeBoer, JB
Sprangers, MAG
Aaronson, NK
Lange, JMA
vanDam, FSAM
机构
[1] NETHERLANDS CANC INST, DIV PSYCHOSOCIAL RES & EPIDEMIOL, 1066 CX AMSTERDAM, NETHERLANDS
[2] WHO, COLLABORATING CTR QUAL LIFE, AMSTERDAM, NETHERLANDS
[3] ERASMUS UNIV ROTTERDAM, DEPT MED PSYCHOL & PSYCHOTHERAPY, ROTTERDAM, NETHERLANDS
[4] ACAD MED CTR, NATL AIDS TREATMENT EVALUAT CTR, AMSTERDAM, NETHERLANDS
[5] UNIV AMSTERDAM, DEPT CLIN PSYCHOL, AMSTERDAM, NETHERLANDS
关键词
AIDS; HIV infections; HOPES; quality of life; reliability; validity;
D O I
10.1007/BF00433918
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The objective of this study was to evaluate the feasibility, reliability, validity and responsiveness of the HIV Overview of Problems Evaluation System (HOPES) in a Dutch sample. The HOPES was administered three times in a one-year period to a sample of 106 outpatients with a symptomatic HIV-infection (n = 23) or AIDS (n = 83). The HOPES is a self-report HIV-specific quality of life (QOL) questionnaire including five scales: physical, psychosocial and sexual functioning, medical interaction and partner relationship. QOL was also assessed with the EORTC Quality of Life Questionnaire (EORTC QLQ-C30), a 30-item self-report instrument. Clinical data included Centers for Disease Control end Prevention (CDC) stage, date of diagnosis and CD4 cell count. Patients needed approximately 20-30 minutes to complete the questionnaire. The five scales had good internal consistency reliability. Multitrait scaling analysis provided moderate support for item discriminant and convergent validity. The HOPES exhibited adequate levels of construct validity: (1) the inter-scale correlations and correlations with the EORTC QLQ-C30 were in the predicted direction; (2) it discriminated clearly between patients with AIDS and ARC and (3) it was able to document changes in QOL over time. Moreover the HOPES was responsive to changes in clinical status over time as indicated by CD4 counts. This study provides further evidence of the reliability and validity of the HOPES and shows that this instrument is responsive to changes in CD4 cell counts.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 21 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
BLOOM J R, 1990, Journal of Psychosocial Oncology, V8, P49, DOI 10.1300/J077v08n01_04
[3]  
CHUANG HT, 1989, AM J PSYCHIAT, V146, P876, DOI 10.1176/ajp.146.7.876
[4]   THE FEASIBILITY, RELIABILITY AND VALIDITY OF THE EORTC QLQ-C30 IN ASSESSING THE QUALITY-OF-LIFE OF PATIENTS WITH A SYMPTOMATIC HIV-INFECTION OR AIDS (CDC-IV) [J].
DEBOER, JB ;
SPRANGERS, MAG ;
AARONSON, NK ;
LANGE, JMA ;
VANDAM, FSAM .
PSYCHOLOGY & HEALTH, 1994, 9 (1-2) :65-77
[5]  
DEGRUTTOLA V, 1993, J ACQ IMMUN DEF SYND, V6, P359
[6]   ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
FRISSEN, PHJ ;
VANDERENDE, ME ;
TENNAPEL, CHH ;
WEIGEL, HM ;
SCHREIJ, GS ;
KAUFFMANN, RH ;
KOOPMANS, PP ;
HOEPELMAN, AIM ;
DEBOER, JB ;
WEVERLING, GJ ;
HAVERKAMP, G ;
DOWD, P ;
MIEDEMA, F ;
SCHUURMAN, R ;
BOUCHER, CAB ;
LANGE, JMA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1351-1355
[7]   DESCRIBING THE HEALTH-RELATED QUALITY-OF-LIFE IMPACT OF HIV-INFECTION - FINDINGS FROM A STUDY USING THE HIV OVERVIEW OF PROBLEMS EVALUATION SYSTEM (HOPES) [J].
GANZ, PA ;
SCHAG, CAC ;
KAHN, B ;
PETERSEN, L ;
HIRJI, K .
QUALITY OF LIFE RESEARCH, 1993, 2 (02) :109-119
[8]  
Hays R., 1988, USERS GUIDE MULTITRA
[9]  
KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO
[10]  
2-L